NASHVILLE, Tenn., Feb. 26, 2020 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading
temperature-controlled logistics company dedicated to the life
sciences industry, today announced a multi-year agreement with
Inception Fertility, LLC ("Inception Fertility"), a
Houston-based company which
operates The Prelude Network, the largest and fastest growing
network of fertility centers in the
United States and MyEggBank, one of the largest frozen donor
egg banks in North America.
Under the terms of this partnership, The Prelude Network and
MyEggBank will utilize Cryoport's temperature-controlled supply
chain solutions to deliver a superior patient experience across its
entire clinical network, which will provide significant risk
mitigation for its clients.
The Prelude Network and MyEggBank will utilize Cryoport's
world-class supply chain management and informatics platform to
process both domestic and international shipments of eggs, embryos
and throughout its global network to help thousands of people grow
their families. In addition to Cryoport assuming
responsibility for all domestic logistics activity, international
shipments are expected to rapidly increase as Cryoport's solutions
will expand Inception Fertility's processing bandwidth.
"The Prelude Network is the fastest-growing network of fertility
clinics and largest provider of comprehensive fertility services in
the U.S. and we are proud they have chosen Cryoport's end-to-end
solutions to manage their supply chain business. Supporting The
Prelude Network will allow us to significantly expand our presence
in the global Reproductive Medicine market. Our partnership comes
as The Prelude Network experiences rapid growth and prioritizes
improved streamlining of business processes across its enterprise
for the protection of its products and services," said Jerrell Shelton, CEO of Cryoport.
T.J. Farnsworth, CEO of Inception Fertility, commented, "As we
continue to expand our network of top tier fertility centers and
serve higher numbers of patients in new geographies, business
efficiency and risk mitigation continues to be a focal point.
We need a supply chain partner that has the scale to support us as
we streamline and grow our network, utilizing a strict set of
operating principles. We are pleased to choose Cryoport's
world-class supply chain management and informatics platform to
ensure we continue to offer a high-quality patient experience for
our clients, no matter where they are in the world."
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is the world's premier
provider of temperature-controlled supply chain solutions for the
life sciences industry, serving the Biopharma, Human
Reproductive, and Animal Health markets. Our mission is to
support life and health on earth by providing reliable and
comprehensive solutions for the life sciences through our advanced
technologies, Global Supply Chain Network and dedicated scientists,
technicians and supporting team of professionals. Through
purpose-built proprietary packaging; information technology; smart,
sustainable cold chain logistics; and biostorage/biobanking
services, Cryoport helps its customers advance life sciences
research, support life-saving advanced therapies and deliver
vaccines, protein producing materials, and IVF treatments in over
100 countries around the world. For more information, visit
www.cryoport.com or follow @cryoport on Twitter
at www.twitter.com/cryoport for live updates.
The Prelude Network
The Prelude Network (Prelude), the fastest-growing network of
fertility clinics and largest provider of comprehensive fertility
services in the U.S., is the clinic network of Inception – a
company whose mission is to shift the paradigm of the fertility
market by raising the standard of care, streamlining fragmented
components into an integrated system and enhancing the overall
patient experience.
Each clinic as part of the Prelude Network is committed to
delivering the highest level of personalized fertility care by the
nation's leading reproductive endocrinologists, embryologists and
practitioners by focusing on an excellence in science, medicine and
the patient experience. The growing Prelude Network has 41 total
locations nationwide, offering a wide range of fertility services
including egg freezing, IVF, genetic testing and egg/embryo
storage, among others.
www.preludefertility.com
MyEggBank
Is the #1 frozen donor egg bank in North America, MyEggBank has helped thousands
of people grow their families with our innovative technology, an
extensive selection of donors and compassionate care for each
family. MEB is one of the pioneers in fertility and was the first
frozen donor egg bank that used vitrification technology. With over
100 affiliate clinics in the MEB network, we have one of the
largest and most diverse selection of egg donors and have been able
to offer patients industry-leading guarantees.
www.myeggbank.com/
Forward Looking Statements
Statements in this news release which are not purely historical,
including statements regarding Cryoport, Inc.'s intentions, hopes,
beliefs, expectations, representations, projections, plans or
predictions of the future are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. It
is important to note that the Company's actual results could differ
materially from those in any such forward-looking statements.
Factors that could cause actual results to differ materially
include, but are not limited to, risks and uncertainties associated
with the effect of changing economic conditions, trends in the
products markets, variations in the Company's cash flow, market
acceptance risks, and technical development risks. The Company's
business could be affected by a number of other factors, including
the risk factors listed from time to time in the Company's SEC
reports including, but not limited to, the Company's 10-K for the
year ended December 31, 2018 filed
with the SEC. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this press
release. Cryoport, Inc. disclaims any obligation, and does not
undertake to update or revise any forward-looking statements in
this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-and-inception-fertility-enter-into-agreement-301011235.html
SOURCE Cryoport, Inc.